OpenArc Corporate Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
OpenArc Corporate Advisory's BMY Position: Q2 2026 in Review
OpenArc Corporate Advisory increased its Bristol-Myers Squibb (BMY) stake by 16% in Q2 2026, buying an estimated $276K and bringing the position to 34,078 shares worth $1.96M. The position accounts for 0.02% of the portfolio, ranked #265.
OpenArc Corporate Advisory first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- OpenArc Corporate Advisory held 34,078 shares of Bristol-Myers Squibb worth $1.96M as of Q2 2026.
- OpenArc Corporate Advisory bought 4,806 Bristol-Myers Squibb shares in Q2 2026, an estimated $276K.
- Bristol-Myers Squibb made up 0.02% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #265 holding.
- OpenArc Corporate Advisory first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.